Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
10/2008
10/09/2008WO2008121194A1 Hydroformylation process
10/09/2008WO2008120660A1 Novel phosphine, method for producing the same and use of the same
10/09/2008WO2008119153A1 Amino phosphine
10/09/2008WO2008071689A3 Process for the manufacture of alkylamino alkylene phosphonic acids
10/09/2008US20080250535 Using vector transformation to express amino acid oxidase and phosphinothricin and preferential destroy or prevent gamete formation in plants
10/09/2008US20080249166 Inhibiting hepatic fatty acid and sterol synthesis; use with statins; compounds such as cyclopropyl or cyclobutyl-functional hydroxy-functional alpha,gamma-alkanediacids
10/09/2008US20080249070 potent, and selective agonists for G protein-coupled receptors (S1P1); to treat autoimmune diseases, such as, uveitis, type I diabetes, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, cancer, neurodegenerative diseases; (1-amino-3-(4-octylphenyl cyclopentyl)methanol
10/09/2008US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
10/09/2008US20080248968 A flat chip having on the surface an array of spots with 3-hydroxypicolinic acid matrix from the deposition of a reproduced, defined and controlled nanoliter scale volume and no analyte
10/09/2008US20080245443 Lubricated surfaces such as gears, bearings; manganese phosphate film on surfaces
10/08/2008EP1534657B1 Process for preparing aldehyde compounds
10/08/2008EP1515934B1 Method for producing c13-alcohol mixtures
10/08/2008CN101283073A Flame retardant composition and method
10/08/2008CN101282981A Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
10/08/2008CN101282980A Stabilization of polyolefins with liquid cyclic phosphites
10/08/2008CN101282979A Composition containing chloromethyl phosphate derivative with improved stability and process for producing the same
10/08/2008CN101282730A Phosphoantigen salts of organic bases and methods for their crystallization
10/08/2008CN101279988A Chiral diphosphine ligand, synthetic method and use thereof
10/08/2008CN101279987A Production process of tenofovir
10/08/2008CN101279986A Synthetic method of axis-unsymmetric chiral diphosphine ligand
10/08/2008CN101279985A Synthetic method of ibandronate
10/08/2008CN101279984A Alkyl phenol sulfonic polyoxyethylene ether phosphate salt and preparation thereof
10/08/2008CN100424259C Room temperature ionic liquid containing unsaturated double bond and its prepn and application
10/08/2008CN100423726C No dump-agglomeration powder phospholipid and preparation process thereof
10/07/2008US7432385 Phosphorous-containing, organic polymerisable silanes and silicic acid polycondensates produced therewith
10/07/2008US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432273 cancer and/or viral infection, leukemia; improved pharmacological properties; oral bioavailability, greater potency, extended half-life in vivo, Side effects reduction; 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-6-diethoxy-phosphoryl)-hexanoic acid, diethyl cyano phosphonate
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008US7432253 Phosphoepoxides, method for making same and uses
10/07/2008US7432246 Sir2 products and activities
10/02/2008WO2008118899A1 Methods and compositions for detecting glyphosate and metabolites thereof
10/02/2008WO2008118699A1 Use of low triphenylphosphate, high phosphorous content isopropyl phenyl phosphates as flame retardants in polyurethane or polyisocyanurate foams
10/02/2008WO2008118695A1 Use of low triphenylphosphate, high phosphorous content isopropyl phenyl phosphates as flame retardants in resins
10/02/2008WO2008117733A1 Process for production of phosphorus-containing α-keto acid
10/02/2008WO2008117054A2 Chiral diphosphines, methods for their preparation, transition metal complexes comprising them and use in chiral synthesis
10/02/2008WO2008075048A3 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments
10/02/2008WO2008073142A3 Novel inhibitors of beta-lactamase
10/02/2008WO2008071691A3 Reactive phosphonates
10/02/2008WO2008068413A3 Method for preparing acetyl,docosahexaenoyl-glycerophosphocholine and use thereof for the delivery of polyunsaturated fatty acids
10/02/2008US20080242893 Process for Preparing Optically Active Diphosphanes
10/02/2008US20080242811 Amino phosphine
10/02/2008US20080242639 Phosphagen Synthesis
10/02/2008US20080242534 Complex containing transition metal and borate; hydrogenation catalyst
10/02/2008CA2682335A1 Chiral phosphorus compounds
10/02/2008CA2679820A1 Methods and compositions for detecting glyphosate and metabolites thereof
10/01/2008EP1975620A2 Three hybrid assay system
10/01/2008EP1975170A1 Bisphosphine ligands for asymmetric syntheses
10/01/2008EP1973923A1 Intermediate compound of technetium nitride complex for radiodiagnostic imaging
10/01/2008EP1973409A2 Novel phytic citrate compounds and process for preparing the same
10/01/2008CN101277968A 铌化合物 Niobium compounds
10/01/2008CN101274973A Alpha-olefin-conjugated diene copolymer
10/01/2008CN101274944A Novel process for producing 2-chloroethyl phosphonic acid by compression method
10/01/2008CN101274943A Synthetic method for disodium creatine phosphate
10/01/2008CN101274942A Preparation of aryl phosphate
10/01/2008CN101274795A Process for treating waste water in chlorfluazuron synthesis
10/01/2008CN100422195C Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation
10/01/2008CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
10/01/2008CN100422145C Method of preparing sulfone amide and method of using said sulfone smine to prepare N-substituted imine
09/2008
09/30/2008US7429671 Process for the fluorination of boron hydrides
09/30/2008US7429628 Method of making a thermoplastic composition containing an antistatic agent
09/30/2008US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
09/30/2008US7429615 Cyclohexyl prostaglandin analogs as EP4-receptor agonists
09/30/2008US7429596 Oxidoreductase inhibitors; anticancer agents; antiinflammatory agents
09/30/2008US7429575 Cosmetics; skin disorders; dermatology
09/30/2008US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use
09/30/2008US7429565 Antiviral phosphonate analogs
09/30/2008CA2377762C Sulfonamidomethyl phosphonate inhibitors of .beta.-lactamase
09/29/2008CA2583007A1 Amino phosphine
09/25/2008WO2008114808A1 Process for producing phosphorus-containing dehydroamino acid
09/25/2008WO2008114584A1 Treating agent for polysaccharide
09/25/2008WO2008113777A1 Method for the production of an alkenyl phosphonic acid derivative
09/25/2008WO2008113161A1 Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same
09/25/2008WO2008082690A3 Phosphorous-based flame retardant recovery method
09/25/2008WO2008055249A3 Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases
09/25/2008US20080234519 by reacting phosphorous acd, an amine and formaldehyde, in the presence of an acid catalysts; one step; efficiency
09/25/2008US20080234405 very quickly cured; particularly suitable for dental purposes
09/25/2008US20080234390 Skin pore minimizers and skin elasticity improvers
09/25/2008US20080234231 Diethyl[2-({[7-[(4-fluorophenyl)methyl]-4-hydroxy-3-({[2-(methyloxy)ethyl]amino}carbonyl)-2-oxo-1,5-naphthyridin-1(2H)-yl]acetyl}amino)ethyl]phosphonate; alone or with a second enzyme inhibitor
09/25/2008DE10222588B4 Biomimetische Systeme aus Lipidmembranen gebunden an ein Substrat Biomimetic systems of lipid membranes bound to a substrate
09/24/2008EP1972643A1 Process for production of phosphate polymer
09/24/2008EP1971615A1 Lysme-based prodrugs of aspartyl protease inhibitors and processes for their preparation
09/24/2008EP1971580A1 Piperazine compounds with a herbicidal action
09/24/2008CN101270132A Method for preparing triphenylphosphine with diphenylbenzene phosphine oxide
09/24/2008CN101270131A Large specific pore volume microsphaeric alpha-benzenephosphonic acid zirconium and preparation method thereof
09/24/2008CN101270130A Method for preparing bi-axungia acyl-phosphatidylethanolamine
09/24/2008CN101270129A Novel method for synthesizing bi-axungia acyl-phosphatidylethanolamine
09/24/2008CN101270127A Succinimide silver complex with steady organo-phosphines, synthesizing method and application thereof
09/24/2008CN101270105A Coumarin compound for enzymatic activity analysis and enzyme inhibitor sifting motion, and synthesizing process
09/24/2008CN101270077A Comprehensive process for tail gas in glyphosate production
09/24/2008CN101270035A Novel method for synthesizing 3-benzyl group glycerol alcohol and application of the compound
09/24/2008CN100420691C Method for synthesizing chlopyrifos in water medium
09/24/2008CN100420443C Nucleotide analog composition and synthesis method
09/23/2008US7427680 Fluorogenic substrates for BETA-lactamase gene expression
09/23/2008US7427678 Reacting a derivatized molecule with a support; diels-alder reaction; fluorescein; diene or dienophile
09/23/2008US7427636 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
09/23/2008US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine
09/18/2008WO2008111371A1 Phosphoroamide compound, method for producing the same, ligand, complex, catalyst, and method for producing optically active alcohol
09/18/2008WO2008111293A1 Rare-earth complex and use thereof
09/18/2008WO2008110611A1 Organic compounds and their uses